98 related articles for article (PubMed ID: 20683603)
1. Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer.
Käufl SD; Kuhn C; Kunze S; Shabani N; Brüning A; Friese K; Mylonas I
Arch Gynecol Obstet; 2011 Jul; 284(1):199-207. PubMed ID: 20683603
[TBL] [Abstract][Full Text] [Related]
2. Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications.
Mylonas I
Eur J Cancer; 2010 Sep; 46(13):2485-93. PubMed ID: 20599374
[TBL] [Abstract][Full Text] [Related]
3. Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?
Mylonas I
Arch Gynecol Obstet; 2011 Aug; 284(2):467-76. PubMed ID: 20865419
[TBL] [Abstract][Full Text] [Related]
4. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
[TBL] [Abstract][Full Text] [Related]
5. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
Mylonas I
Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065
[TBL] [Abstract][Full Text] [Related]
6. Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.
Blankenstein T; Jückstock J; Shabani N; Kunze S; Brüning A; Bergauer F; Mylonas I
Oncol Rep; 2011 Jan; 25(1):147-52. PubMed ID: 21109970
[TBL] [Abstract][Full Text] [Related]
7. Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases.
Mylonas I; Worbs S; Shabani N; Kuhn C; Kunze S; Schulze S; Dian D; Gingelmaier A; Schindlbeck C; Brüning A; Sommer H; Jeschke U; Friese K
Eur J Cancer; 2009 May; 45(7):1304-1314. PubMed ID: 19231155
[TBL] [Abstract][Full Text] [Related]
8. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
[TBL] [Abstract][Full Text] [Related]
9. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
[TBL] [Abstract][Full Text] [Related]
10. Inhibin/activin-betaC subunit in human endometrial adenocarcinomas and HEC-1a adenocarcinoma cell line.
Käufl SD; Makovitzky J; Kuhn C; Kunze S; Jeschke U; Mylonas I
In Vivo; 2010; 24(5):695-8. PubMed ID: 20952735
[TBL] [Abstract][Full Text] [Related]
11. The inhibin-βC subunit is down-regulated, while inhibin-βE is up-regulated by interferon-β1a in Ishikawa carcinoma cell line.
Jückstock J; Kimmich T; Mylonas I; Friese K; Dian D
Arch Gynecol Obstet; 2013 Oct; 288(4):883-8. PubMed ID: 23580013
[TBL] [Abstract][Full Text] [Related]
12. Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line.
Burges A; Shabani N; Brüning A; Mylonas I
Arch Gynecol Obstet; 2011 Oct; 284(4):981-8. PubMed ID: 21082187
[TBL] [Abstract][Full Text] [Related]
13. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
[TBL] [Abstract][Full Text] [Related]
14. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
15. Inhibin beta B: a useful tumor marker in uterine endometrioid adenocarcinomas?
Mylonas I
Histol Histopathol; 2011 Nov; 26(11):1415-22. PubMed ID: 21938679
[TBL] [Abstract][Full Text] [Related]
16. Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma.
Gingelmaier A; Gutsche S; Mylonas I; Shabani N; Kuhn C; Kunze S; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):2011-7. PubMed ID: 17649814
[TBL] [Abstract][Full Text] [Related]
17. Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.
Mylonas I; Shabani N; Vogl J; Makovitzky J; Kunze S; Kuhn C; Schulze S; Friese K; Jeschke U
Anticancer Res; 2007; 27(4A):1995-2000. PubMed ID: 17649811
[TBL] [Abstract][Full Text] [Related]
18. The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
Hoeing A; Kuhn C; Shabani N; Schulze S; Gingelmaier A; Dian D; Jeschke U; Friese K; Mylonas I
Anticancer Res; 2007; 27(4A):2005-10. PubMed ID: 17649813
[TBL] [Abstract][Full Text] [Related]
19. Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue.
Mylonas I; Brüning A; Shabani N; Kunze S; Kupka MS
Reprod Biol Endocrinol; 2010 Nov; 8():143. PubMed ID: 21092084
[TBL] [Abstract][Full Text] [Related]
20. Inhibin-betaC subunit expression in normal and pathological human placental tissues.
Mylonas I; Makovitzky J; Kunze S; Brüning A; Kainer F; Schiessl B
Syst Biol Reprod Med; 2011 Aug; 57(4):197-203. PubMed ID: 21117833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
